KCR’s employee team exceeded 400 people in November this year. Our contract research organization (CRO) has been focusing on the company’s organic growth and keeping it sustainable. 2018 was a year of a successful development across all areas of KCR’s activities. As of today, the company successfully operates across 4 regions, with main offices in Boston, Berlin, Warsaw and Kiev.
“Reaching over 400 employees is another milestone in our company growth. We develop as a company, we grow as a team, but at the same time we manage to maintain a flat organizational structure and friendly and cooperative atmosphere,” said Mike Jagielski, CEO of KCR.
KCR’s diversified service portfolio, which includes clinical trial execution, trial execution consulting and functional service provision, positions the company as an attractive solution provider for biopharma. The operational teams leverage local knowledge and efficient management to ensure high quality services delivery for clinical trials.
KCR focuses on the career development of its employees, with strong training and knowledge management. This is to encourage people to take new opportunities and broaden their skills and competencies.
“You cannot buy culture, culture has to be developed. We are in a fortunate situation that we are a 100% private company with no pressure from investors to search for the next M&A opportunity. This really allows us to focus on the development of a cohesive team and company culture for the benefit of our growing customer base,” added KCR’s CEO.
“Offering a high level of stability and predictability is a factor in the decision-making process of biopharma clients. And no, we do not have an “Exit Strategy”. Our focus is entirely on developing the team, the service offering and advancing our project portfolio. We still have more ideas than time to implement. I think that KCR is a good place to be in, “summarized Mr. Jagielski.
KCR is a contract research organization providing clinical development solutions for the pharmaceutical, biotechnology and medical device industries. The company supports clients with full-service capabilities across three main services: Trial Execution (TE), Functional Service Provision (FS) and Trial Execution Consulting (TC) over a broad range of therapeutic areas. KCR operates across four main regions: North America, Western Europe, Central Europe, and Eastern Europe with hubs located in Boston, U.S., Berlin, Germany, Warsaw, Poland and Kiev, Ukraine. KCR’s geographical locations allow for optimized delivery of trial execution strategies to develop life-changing therapies.
KCR: We see human behind every number.
Associate Director, PR & Marketing
mobile: (+48) 605 053 164